BCV
PFE icon

Banque Cantonale Vaudoise’s Pfizer PFE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$1.72M – 1383
2021
Q3 		$1.72M Buy
+400
New +$17.7K 0.07% 260
2021
Q1 		– Sell
-200
Closed -$736K – 1181
2020
Q4 		$736K Buy
+200
New +$7.34K 0.04% 385

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Banque Cantonale Vaudoise's PFE Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Pfizer (PFE) stake by 94% in Q2 2026, buying an estimated $3.64M and bringing the position to 286,435 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Banque Cantonale Vaudoise first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $17.9M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Banque Cantonale Vaudoise held 286,435 shares of Pfizer worth $6.9K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 139,113 Pfizer shares in Q2 2026, an estimated $3.64M.
  • Pfizer made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #241 holding.
  • Banque Cantonale Vaudoise first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's Pfizer position peaked at $17.9M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.